[Effect of neovir in the treatment of acute hepatitis C].
Fifteen male patients with acute hepatitis C aged 16-44 years were treated with neovir, an interferon inducer, administered intramuscularly in a daily dose of 250 mg 2-3 times a week for 3 months. By the end of this therapy the RNA of hepatitis C virus could still be detected in 84.6% of the patients, the characteristics of ALT, AST and alkaline phosphatase exceeded the norm more than twofold. The results of neovir therapy are regarded as ineffective.
Maksimov
S L
SL
State Medico-Stomatological University, City Clinical Infectious Hospital No. 2, Central Research Unstitute of Epidemiology, Moscow, Russia.
Iushchuk
N D
ND
Roslyĭ
I M
IM
Kravchenko
A V
AV
Danilova
T V
TV
D000166:Acridines / Q000627:therapeutic use*; D000208:Acute Disease; D016174:Hepacivirus / Q000235:genetics; D006526:Hepatitis C / Q000188:drug therapy*; D006801:Humans; D007369:Interferon Inducers / Q000627:therapeutic use*; D008297:Male; D012367:RNA, Viral / Q000097:blood; D000637:Transaminases / Q000097:blood
D000166:Acridines; D007369:Interferon Inducers; D012367:RNA, Viral; C077681:Camedon; D000637:Transaminases